Evidence map›Paper›PMID 38911387›Full record

ArticleJournal of Cancer2024

Development and validation of matrix metalloproteinase for predicting prognosis and tumour microenvironment immune profiles in uterine corpus endometrial carcinoma.

Huancheng Su, Yutong Yang, Chu Li, Jinpeng Li, Huihui Lv, Xiaoyao Jia, Jiaolin Yang, Jing Lei, Xia Li, Hongrui Guo and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Huancheng SuShanxi Medical University, Taiyuan 030001, China.
Yutong YangShanxi Medical University, Taiyuan 030001, China.
Chu LiDepartment of Tuina, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, China.
Jinpeng LiShanxi Medical University, Taiyuan 030001, China.
Huihui LvShanxi Medical University, Taiyuan 030001, China.
Xiaoyao JiaShanxi Medical University, Taiyuan 030001, China.
Jiaolin YangDepartment of Gynecology, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Jing LeiDepartment of Gynecology, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Xia LiShanxi Medical University, Taiyuan 030001, China.
Hongrui GuoDepartment of Gynecology, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Zhe WangShanxi Medical University, Taiyuan 030001, China.
Sanyuan ZhangShanxi Medical University, Taiyuan 030001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Endometrial cancer (EC)Immune checkpointImmune infiltrationMatrix metalloproteinases (MMPs)Tumour microenvironment (TME)Tumour mutation burden (TMB)

Identifiers

PMID38911387
PMCPMC11190773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.